127 related articles for article (PubMed ID: 32224157)
1. Health-related quality of life in patients with immune mediated inflammatory diseases: A cross-sectional, multidisciplinary study.
Spierings J; Sloeserwij A; Vianen ME; de Boer JH; Sigurdsson V; van de Wijgert JHHM; van Laar JM
Clin Immunol; 2020 May; 214():108392. PubMed ID: 32224157
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.
Rizzello F; Olivieri I; Armuzzi A; Ayala F; Bettoli V; Bianchi L; Cimino L; Costanzo A; Cristaudo A; D'Angelo S; Daperno M; Fostini AC; Galeazzi M; Gilio M; Gionchetti P; Gisondi P; Lubrano E; Marchesoni A; Offidani A; Orlando A; Pugliese D; Salvarani C; Scarpa R; Vecchi M; Girolomoni G
Adv Ther; 2018 Apr; 35(4):545-562. PubMed ID: 29516409
[TBL] [Abstract][Full Text] [Related]
3. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
[TBL] [Abstract][Full Text] [Related]
4. Increased incidence of psychiatric disorders in immune-mediated inflammatory disease.
Marrie RA; Walld R; Bolton JM; Sareen J; Walker JR; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
J Psychosom Res; 2017 Oct; 101():17-23. PubMed ID: 28867419
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
Bellinger DL; Lorton D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts.
Fernández-Gutiérrez B; Perrotti PP; Gisbert JP; Domènech E; Fernández-Nebro A; Cañete JD; Ferrándiz C; Tornero J; García-Sánchez V; Panés J; Fonseca E; Blanco F; Rodríguez-Moreno J; Carreira P; Julià A; Marsal S; Rodriguez-Rodriguez L;
Medicine (Baltimore); 2017 Jun; 96(26):e7308. PubMed ID: 28658137
[TBL] [Abstract][Full Text] [Related]
7. Quality of Life in Patients with Noninfectious Uveitis Treated with or without Systemic Anti-inflammatory Therapy.
Gui W; Dombrow M; Marcus I; Stowe MH; Tessier-Sherman B; Yang E; Huang JJ
Ocul Immunol Inflamm; 2015 Apr; 23(2):135-43. PubMed ID: 24867459
[TBL] [Abstract][Full Text] [Related]
8. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
Shobha V; Chandrashekara S; Rao V; Desai A; Jois R; Dharmanand BG; Kumar S; Kumar P; Dharmapalaiah C; Mahendranath KM; Prasad S; Daware MA; Singh Y; Karjigi U; Nagaraj S; Anupama KR
Int J Rheum Dis; 2019 Feb; 22(2):280-287. PubMed ID: 30168281
[TBL] [Abstract][Full Text] [Related]
9. Effect of immunosuppressive drugs in immune-mediated inflammatory disease during the coronavirus pandemic.
Giuliani F; Gualdi G; Amerio P
Dermatol Ther; 2020 Nov; 33(6):e14204. PubMed ID: 32829511
[TBL] [Abstract][Full Text] [Related]
10. Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases.
Pereira R; Faria R; Lago P; Torres T
Curr Drug Saf; 2017; 12(3):162-170. PubMed ID: 28625143
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and related factors in a cohort of plaque-type psoriasis patients in La Coruña, Spain.
Fernández-Torres RM; Pita-Fernández S; Fonseca E
Int J Dermatol; 2014 Nov; 53(11):e507-11. PubMed ID: 25266080
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities and health-related quality of life in Spanish patients with moderate to severe psoriasis: a cross-sectional study (Arizona study).
Sanchez-Carazo JL; López-Estebaranz JL; Guisado C
J Dermatol; 2014 Aug; 41(8):673-8. PubMed ID: 24942203
[TBL] [Abstract][Full Text] [Related]
13. Chronologic order of appearance of immune-mediated inflammatory diseases relative to diagnosis of psoriasis.
Andersen YMF; Wu JJ; Thyssen JP; Egeberg A
J Am Acad Dermatol; 2019 Dec; 81(6):1283-1291. PubMed ID: 31009673
[TBL] [Abstract][Full Text] [Related]
14. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
[TBL] [Abstract][Full Text] [Related]
15. Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001-2002.
Robinson D; Hackett M; Wong J; Kimball AB; Cohen R; Bala M;
Curr Med Res Opin; 2006 May; 22(5):989-1000. PubMed ID: 16709321
[TBL] [Abstract][Full Text] [Related]
16. Acceptable quality of life and low disease activity achievable among transition phase patients with rheumatic disease.
Relas H; Kosola S
Clin Rheumatol; 2019 Mar; 38(3):785-791. PubMed ID: 30374749
[TBL] [Abstract][Full Text] [Related]
17. Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.
Vanaclocha F; Crespo-Erchiga V; Jiménez-Puya R; Puig L; Sánchez-Carazo JL; Ferrán M; Sancho C; Juliá B; Cea-Calvo L; Marín-Jiménez I; García-Vicuña R;
Actas Dermosifiliogr; 2015; 106(1):35-43. PubMed ID: 25091923
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 months.
Bae SC; Cho SK; Won S; Lee HS; Lee SH; Kang YM; Lee SH; Lee YA; Choe JY; Chung WT; Suh CH; Shim SC; Lee J; Yoon BY; Kim DW; Lee SS; Yoo WH; Kim JS; Jung YO; Nah SS; Lee CK; Song GG; Choi SJ; Joung CI; Koh H; Kim YJ
Int J Rheum Dis; 2018 May; 21(5):1001-1009. PubMed ID: 29878615
[TBL] [Abstract][Full Text] [Related]
19. Incidence and temporal trends of co-occurring personality disorder diagnoses in immune-mediated inflammatory diseases.
Blaney C; Sommer J; El-Gabalawy R; Bernstein C; Walld R; Hitchon C; Bolton J; Sareen J; Patten S; Singer A; Lix L; Katz A; Fisk J; Marrie RA;
Epidemiol Psychiatr Sci; 2020 Jan; 29():e84. PubMed ID: 31915099
[TBL] [Abstract][Full Text] [Related]
20. Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis.
Shan J; Zhang J
Joint Bone Spine; 2019 Mar; 86(2):173-183. PubMed ID: 29635017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
